Lung cancer specialists know the importance of a multi-disciplinary approach ... and so do we.
Lung cancer specialists know the importance of a multi-disciplinary approach ... and so do we.
ung cancer specialists often collaborate across disciplines in tumor boards to improve patient care. We also value cross-discipline collaboration. That’s why we have the Lung Cancer Initiative at Johnson & Johnson, a multidisciplinary R&D team working across medical technology, pharmaceutical and behavioral-change groups striving to prevent, intercept and treat lung cancer.
Nature
Produced by Johnson & Johnson and Nature Research Custom Media in December 2020
